Grade | IMRT/VMAT(n = 60) | ||
---|---|---|---|
Acute toxicity | Neutropenia | 1–2 | 26 (43.3%) |
3–4 | 12 (20%) | ||
Anemia | 1–2 | 31 (51.7%) | |
3–4 | 23 (38.3%) | ||
Thrombocytopenia | 1–2 | 5 (8.33%) | |
3–4 | 13 (21.7%) | ||
Dermatitis | 1–2 | 14 (23.3%) | |
3–4 | 1 (1.67%) | ||
Nausea | 1–2 | 16 (26.7%) | |
3–4 | 0 | ||
Enterocolitis | 1–2 | 22 (36.7%) | |
3–4 | 1 (1.67%) | ||
Proctitis | 1–2 | 18 (30%) | |
3–4 | 0 | ||
Cystitis | 1–2 | 11 (18.3%) | |
3–4 | 0 | ||
Late toxicity | Enterocolitis | 1–2 | 7 (11.7%) |
3–4 | 1 (1.67%) | ||
Proctitis | 1–2 | 2 (3.33%) | |
3–4 | 0 | ||
Cystitis | 1–2 | 5 (8.33%) | |
3–4 | 0 |